The DST as a predictor of outcome in depression: a meta-analysis

10.1001/archpsyc.1979.01780080009002

10.1176/ajp.139.4.438

10.1192/bjp.153.6.752

10.1192/bjp.153.6.741

10.1056/NEJM198808183190706

10.1001/archpsyc.1976.01770090029002

10.1016/S0193-953X(18)30968-7

10.1001/archpsyc.1982.04290090031007

Nemeroff CB: The role of corticotropin-releasing pathogenesis of major depression. Pharmacopsychiatry 21:76-82

Nemeroff CB, Clinical significance of psychoneuroendocrinology in psychiatry: focus on the thyroid and adrenal. J Clin Psychiatry 1 989

10.1001/archpsyc.1981.01780260017001

10.1001/archpsyc.1985.01790350067012

The APA Task Force on Laboratory Tests in Psychiatry: The dexamethasone suppression test: an overview of its current status in psychiatry. Am J Psychiatry I 987; 144:1253-1262

10.1136/bmj.2.5707.480-d

10.1176/ajp.137.3.383a

10.1176/ajp.137.10.1260

10.1016/S0140-6736(80)91647-5

10.1016/S0140-6736(80)92971-2

Greden JF, 1980, Biol Psychiatry, 15, 449

10.1111/j.1600-0447.1980.tb00576.x

10.1176/ajp.139.1.129

Greden JF, 1982, Biol Psychiatry, 17, 455

Weller EB, Cantwell ML

10.1016/0165-0327(89)90010-4

10.1001/archpsyc.1980.01780200025002

10.1016/0165-1781(81)90008-1

10.1016/0165-1781(82)90062-2

10.1097/00004714-198610000-00007

Albala AA, Tarika J

10.1016/0165-0327(82)90039-8

10.1016/0165-1781(82)90018-X

Coryell W, 1983, Biol Psychiatry, 18, 21

Greden JF, Kronfol Z: Dexamethasone suppression tests in antidepressant treatment of melancholia: the process of normalization and test-retest reproducibility. Arch Gen Psychiatry I 983

Peselow ED, 1983, Psychopharmacol Bull, 19, 87

Targum SD, 1983, Biol Psychiatry, 18, 3

10.1016/0165-0327(83)90041-1

Nemeroff CB, 1984, Am J Psychiatry, 14, 247

Targum SD, 1984, Biol Psychiatry, 19, 305, 10.1016/0301-0511(84)90045-0

Yerevanian BI, 1984, Biol Psychiatry, 19, 407

10.1192/bjp.147.1.30

10.1192/bjp.146.3.294

10.1016/0306-4530(85)90003-4

10.1192/bjp.147.4.453

10.1016/0006-3223(85)90064-2

Baumgartner A, Kurten I: Serial dexamethasone suppression tests in psychiatric illness, part II: a study in major depressive disorder. Psychiatry Res 1 986

10.1016/0165-0327(86)90055-8

Lipman RS, 1986, Convulsive Therapy, 2, 151

Lipman RS, II: six-month follow-up. Convulsive Therapy I 986

Maes M, Dc Ruyter M, Hobin P, Suy E: Repeated dexamethasone suppression test in depressed patients. J Affect Disord I 986; 11:165-1 72

10.1016/0165-0327(86)90005-4

10.1177/070674378703200303

10.1016/0006-3223(87)90168-5

Grunhaus L, 1987, Zis AP

10.1192/bjp.150.3.315

10.1176/ajp.144.1.30

10.1192/bjp.151.6.780

10.1001/archpsyc.1991.01810300037005

10.1176/ajp.136.10.1328

Holsboer F, Maier W: Four cases of reversion to abnormal dexamethasone suppression test response as indicator of clinical relapse: a preliminary report. Biol Psychiatry I 983

10.1192/bjp.145.6.591

. Greden JF: Clinical applications of serial dexamethasone suppression tests. Fair Oaks Hosp Psychiatry Letter 1985; 3(3)

10.1056/NEJM198702193160806

10.4135/9781412984980

10.1176/ajp.1979.136.4b.543

Schlesser MA, Scientific Proceedings of the 37th Annual Meeting of the Society of Biological Psychiatry

Ettigi PG, 1983, Biol Psychiatry, 18, 499

Arato M, Grof P: Dexamethasone suppression test as a predictor of drug treatment response. Prog Neuropsychopharmacol Biol Psychiatry I 984

10.1159/000118105

Coryell W, Turner R: Outcome with desipramine therapy in subtypes ofnonpsychotic major depression.J Affect Disord 1985

10.1016/0278-5846(89)90007-9

Extein I, 1982, Int J Psychiatry Med, 83, 267

10.1056/NEJM198211043071918

Green HS, Kane JM: The dexamethasone suppression test in depression. Clin Neuropharmacol 1 983

Gitlin MJ, 1984, J Clin Psychiatry, 45, 387

10.1016/0028-3908(84)90072-8

10.1016/0006-3223(85)90094-0

Peselow ED, Wright R: Dexamethasone suppression test in predicting response to tricyclic antidepressants in depressed outpatients. Psychopathology I 985

10.1097/00004714-198610000-00005

10.1016/0022-3956(87)90033-1

10.1111/j.1600-0447.1987.tb02874.x

10.1176/ajp.145.9.1153

10.1192/bjp.152.5.657

10.1097/00004714-198812000-00007

10.1111/j.1600-0447.1988.tb05192.x

10.1192/S0007125000018171

10.1176/ajp.147.11.1488

10.1016/0165-1781(81)90015-9

10.1136/bmj.283.6306.1609-b

10.1007/BF00427493

10.1176/ajp.140.7.844

10.1192/bjp.144.3.311

Janicak PG, 1987, J Clin Psychiatry, 48, 480

Faber R, Bixler G: Dextroamphetamine and dexamethasone suppression test prediction of desipramine response. Biol Psychiatry I 989

10.1176/ajp.140.6.786

Brown WA, 1987, Psychopharmacol Bull, 23, 155

Preskorn SH, Bolte K: Depression in prepubertal children: dexamethasone nonsuppression predicts differential response to imipramine vs placebo. Psychopharmacol Bull 1 987

10.1016/0006-3223(88)90128-X

10.1192/bjp.150.6.787

10.1176/ajp.144.2.212

10.1016/0165-0327(90)90086-N

Carroll B, 1980, Recent Advances in Neuropsychopharmacology: Selected Papers From the I 2th Congress ofthe Collegium Internationale Neuro-Psychopharmacologicum. Edited by Angrist B

10.1176/ajp.138.8.1120

10.1176/ajp.140.7.877

Robbins DR, Alessi NE: Suicide and the dexamethasone pression test in adolescence. Biol Psychiatry 1 985; 20:94-119 sup

10.1016/0165-1781(86)90079-X

10.1111/j.1600-0447.1989.tb10258.x

Carroll BJ, 1972, Charles C Thomas

10.1016/S0140-6736(80)90931-9

10.1176/ajp.138.7.979

1 . Godwin CD, Greenberg LB, Shukia 5: Predictive value of the dexamethasone suppression test in mania. Am J Psychiatry I 984; 141:1610-1612

10.1016/0165-0327(86)90049-2

Gitlin MJ

10.1016/0006-3223(91)90353-N

Breier A, Pickar D: National Institute of Mental Health longitudinal study of chronic schizophrenia: prognosis and predictors of outcome. Arch Gen Psychiatry I 991

10.1159/000284791

Rothschild AJ, Samson JA

10.1016/0006-3223(86)90185-X

10.1097/00004714-198706000-00003

Brown WA, Miller I: Consistency of pituitary-adrenocortical function across multiple psychiatric hospitalizations. Psychiatry Res I 986

Grunhaus L, 1983, Biol Psychiatry, 18, 1497

10.1016/0165-1781(83)90061-6

10.1176/ajp.143.4.539

Rush JA, 1984, Psychotherapy Research: Where Are We and Where Should We Go?

10.1016/0165-0327(89)90031-1

10.1001/archpsyc.1990.01810240013002

10.1055/s-2007-1019496

10.1001/archpsyc.1985.01790300107017

10.1176/ajp.140.1.88

10.1016/0006-3223(86)90306-9

Starkman MN, Schteingart DE

10.1097/00005053-199101000-00009

Murphy BE, Keller R: Response to steroid suppression in major depression resistant to antidepressant therapy.J Clin Psychopharmacol I 991

Carroll BJ, 1985, J Clin Psychiatry, 46, 13

Hellebuyck H, 1988, Acta Psychiatr Belg, 88, 378

Insel TR, 1983, Hosp Community Psychiatry, 34, 1131

10.1016/0090-3019(84)90040-5

Decina P, 1983, Psychopharmacol Bull, 19, 85

10.1016/0165-1781(83)90052-5

10.1016/0022-3956(87)90018-5

10.1016/0165-1781(83)90068-9

10.1016/0165-1781(83)90067-7

10.1016/0197-2456(87)90155-3

10.1176/ajp.126.7.983